SCHEDULE 13G/A Filing for Harmony Biosciences Holdings Inc

This filing is an amendment (Amendment No. 3) to a SCHEDULE 13G filed by The Vanguard Group, Inc. concerning Harmony Biosciences Holdings Inc. The filing indicates that as of March 13, 2026, The Vanguard Group, Inc. no longer holds beneficial ownership of the securities reported. This change is due to an internal realignment on January 12, 2026, where certain subsidiaries and business divisions of The Vanguard Group, Inc. began reporting their beneficial ownership separately. Consequently, The Vanguard Group, Inc. itself no longer has or is deemed to have beneficial ownership over these securities. The filing specifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.